Besides the inhibition of cholinesterase by phenolic compounds, which provides a remedy for Alzheimer’s disease, they equally inhibit the carbohydrate hydrolyzing enzyme, which is a suitable strategy to combat type 2 diabetes mellitus and hyperglycemia, and reduce blood glucose levels [59]. Here, BCHE is linked to early-onset autosomal dominant Alzheimer disease.